DiscoverEAU Podcasts
EAU Podcasts
Claim Ownership

EAU Podcasts

Author: European Association of Urology

Subscribed: 40Played: 1,012
Share

Description

This is the official podcast channel of the European Association of Urology and the European School of Urology. The EAU Podcast is your source for the latest information across the full urological spectrum. Take your clinical practice to new heights and tune in!
101 Episodes
Reverse
In this special edition of EAU Podcasts, Panel Chair Prof. Philip Cornford (GB) and Vice Chair Prof. Derya Tilki (DE) discuss the latest updates in the EAU Guidelines on Prostate Cancer.This expert discussion details an update on the issues around nodal involvement in prostate cancer, as well as the management and staging challenges in the 2024 Guidelines. This discussion took place during the EAU Annual Congress (EAU24) in Paris.
In this special edition of EAU Podcasts, panel experts Drs. A. Van Uitert (NL) and Dr. L. A. 't Hoen (NL) met in person at EAU24 to discuss the newest updates to the EAU Guidelines on Paediatric Urology. In their discussion, they cover updates in six chapters, including trauma, congenital lower urinary tract obstruction, fertility preservation, and transitioning to future paediatric care, including minimally invasive sugery.
Welcome to 'Episode 4' of the series “What young urologists need to know", titled "Effective time management for busy urologists: techniques and tools”, where Prof. Francesco Montorsi (IT) and Dr. Laura Mertens (NL) discuss time management tailored specifically for busy urologists.Dr. Mertens and Prof. Montorsi uncover strategies essential for optimising your workflow. They share invaluable techniques and tools to help you enhance your productivity, from mastering task prioritisation to...
In this special edition of EAU Podcasts, experts met in person at the EAU Annual Congress (EAU24) to discuss the newest updates to the EAU Guidelines on muscle-invasive and metastatic bladder cancer (MIBC). Panel chair Prof. J.A. Witjes led the conversation with co-chair Assoc. Prof. A. Van Der Heijden and panel member Prof. R. Cathomas to cover additions to the local imaging recommendations, restaging and new tools, systemic reviews to the guidelines, and combination therapies.
In this special edition of EAU Podcasts, experts Prof. Paolo Gontero and Prof. Alexandra Masson-Lecomte met in person at the EAU Annual Congress (EAU24) to discuss the newest updates to the EAU Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma (UTUC).Panel Chairs Prof. Paolo Gontero and Prof. Alexandra Masson-Lecomte cover points of change in the UTUC guidelines, including genetic testing recommendations, risk classifications, and treatment recommendations.
In 'Episode 3' of the series “What young urologists need to know", titled "Mentorship and peer support: Navigating urology together”, Prof. Prokar Dasgupta (GB) and Assoc. Prof. Juan Luis Vásquez (DK) talk about the crucial role of mentorship and peer support in the field of urology.They discuss how guidance from experienced mentors and collaboration among peers can enhance professional growth, clinical skills, and overall well-being in the challenging realm of urological practice. ...
Tune in to 'Episode 2' of the series “What young urologists need to know", titled "Academic - clinics balance: How to achieve it?", where Prof. Bhaskar Somani (GB) and Ass. Prof. Giorgio Gandaglia (IT) navigate the delicate equilibrium between academia and clinical practice in urology. In their discussion they share insightful strategies and personal experiences on balancing research commitments with patient care responsibilities. Whether you're a seasoned practitioner or an aspiring academic...
In 'Episode 1' of the series on "What young urologists need to know", segment 2 covers the topic of "Balancing the life of a young urologist". Dr. Thomas Tailly (BE) and Dr. Michiel Sedelaar (NL) offer a comprehensive exploration of the age-old question: Is it truly possible to strike a balance between work and well-being? Dr. Tailly and Dr. Sedelaar delve into the intricate interplay between work and well-being. Through their insightful discussion and evidence-based insights, you can ga...
In 'Episode 3', the final of the series on "Metastatic renal cell carcinoma", Dr. Andrea Mari (IT) talks with Dr. Chiara Ciccarese (IT) from the Medical Oncology Unit at Fondazione Policlinico Universitario A. Gemelli IRCCS, in Rome. Together they have an in-depth discussion on "Beyond first-line treatment strategies for metastatic renal cell carcinoma".Dr. Mari and Dr. Ciccarese delve into recent advancements in managing mRCC, including therapeutic options, and their impact on patient care a...
In 'Episode 2' of the series on "Metastatic renal cell carcinoma", Dr. Andrea Mari (IT) talks to Dr. Laura Marandino (GB) about "The first-line treatment strategies for metastatic renal cell carcinoma".Dr. Andrea Mari and Dr. Laura Marandino unravel the complexities of mRCC management, exploring the latest advancements, therapeutic options, and their implications for patient care. From targeted therapies to immunotherapies, they provide a comprehensive overview of the evolving treatment lands...
UROONCO PCa associate editor Dr. Constance Thibault (FR) talks to Prof. Christophe Hennequin from Saint-Louis Hospital, France about the GETUG-AFU 18 trial results he presented at ASCO GU24 in San Francisco. Prof. Hennequin shares details on the design of the study, followed by the trial results of long-term dose escalation (80 vs 70Gy) combined with long-term androgen deprivation in high-risk prostate cancer. For more details on this study, you can read this abstract on the UROONCO Pro...
In 'Episode 1' of a series on "Metastatic renal cell carcinoma", Assist. Prof. Andrea Mari (IT) and Prof. Ketan Badani (US) discuss "The role of cytoreductive nephrectomy for metastatic renal cell carcinoma ".Assist. Prof. Andrea Mari and Prof. Ketan Badani delve into the pivotal role of cytoreductive nephrectomy in the management of metastatic renal cell carcinoma (mRCC). They talk about the rationale behind this surgical intervention, its impact on patient outcomes, and the evolving landsca...
In this podcast, UROONCO RCC chief editor Dr. Carmen Mir (ES) interviews Prof. Michael Hofman from the Peter MacCallum Cancer Centre, Australia, on the results of his study “First-in-human safety, imaging and dosimetry of [68Ga]Ga-DPI-4452, a novel CA IX-targeting peptide, in patients with clear cell renal cell carcinoma (ccRCC)”. Prof. Hofman discusses the data he presented at ASCO GU24 in San Francisco and suggests that these first-in-human findings with radiolabelled DPI-4452 are enco...
In this podcast, UROONCO RCC chief editor Dr. Carmen Mir interviews Prof. Nizar Tannir from the University of Texas, MD Anderson Cancer Center, USA, on the long-term follow-up data from the phase 3 CheckMate 214 trial: Nivolumab plus ipilimumab (NIVO+IPI) vs sunitinib (SUN) for first-line treatment of advanced renal cell carcinoma (aRCC). Prof. Tannir summarises the history and stability of the Checkmate 214 trial results over the last 8 years, before discussing the latest data from his ...
In this podcast interview live from ASCO GU24 in San Francisco, UROONCO PCa associate editor Dr. Constance Thibault (FR) talks to medical oncologist Dr. Kim Chi from the University of British Columbia, Canada, about the CONTACT-2 trial. This randomised phase 3 trial aimed to evaluate the efficacy of cabozantinib + atezolizumab vs. second novel hormonal therapy in patients with metastatic castration-resistant prostate cancer (mCRPC).Dr. Chi shares his interpretation of the study design and the...
In this podcast, UROONCO RCC chief editor Dr. Carmen Mir (ES) interviews Assoc. Prof. Pedro Barata from University Hospitals Seidman Cancer Center, USA, about the results of two adjuvant RCC studies: KEYNOTE-564; and CheckMate-914.Assoc. Prof. Barata explains the positive trial results of KEYNOTE-564, which is the first time there has been an overall survival advantage with a PD-1 inhibitor in the pure adjuvant setting in RCC. These results support adjuvant pembrolizumab as a standard of care...
In this podcast, UROONCO BCa chief editor Dr. Benjamin Pradere (FR) interviews medical oncologist Dr. Andrea Apolo from the National Cancer Institute, USA, on the results of the AMBASSADOR study, which she presented at ASCO GU24. Dr. Apolo shares details on the rationale of the AMBASSADOR study: An open-label, randomised, phase III trial, evaluating the efficacy and safety of pembrolizumab as an adjuvant treatment in muscle-invasive and locally advanced urothelial carcinoma (MIUC). ...
In this podcast, UROONCO BCa chief editor Dr. Benjamin Pradere (FR) interviews Dr. Srikala Sridhar (CA), about her abstract she recently presented at ESMO 2023, PET-MUSE: “Impact of positron emission tomography (PET) imaging on staging of muscle-invasive bladder cancer (MIBC)”.Dr. Sridhar shares details on the rationale and design of the study, as well as some interesting results.For more details on this study, you can read this abstract on the UROONCO Bladder Cancer educational platform.
In this edition, Dr. Aisling Nic an Riogh (IE), a member of the EAU Guidelines panel for Non-neurogenic female LUTS, discusses bladder outlet obstruction (BOO) in women.Dr. Nic an Riogh defines bladder outlet obstruction, its prevalence, and the various symptoms. She further explains that BOO can be divided into two main groups, anatomical (physical or mechanical), and functional (non-anatomical, non-urogenic). It is diagnosed via urodynamics, and Dr. Nic an Riogh discusses the various ...
In this podcast, UROONCO RCC board members, chief editor Dr. Carmen Mir (ES), and associate editors Dr. Riccardo Bertolo (IT) and Dr. Teele Kuusk (GB), discuss the progress made in the field of kidney cancer during 2023, and what is anticipated for 2024.Some topics discussed include the game-changing ZIRCON trial, OpeRa trial, and 3D models in PN and single-port RPN, as well as SBRT – FASTRACK II. Adjuvant IO, first-line mRCC treatments (KEYNOTE-426), and RN is also reviewed.The main WH...
loading
Comments 
Download from Google Play
Download from App Store